Kunj Vyas B. Pharm., Maharshsinh Rathod B. Pharm., Mayur M. Patel PhD
{"title":"Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer","authors":"Kunj Vyas B. Pharm., Maharshsinh Rathod B. Pharm., Mayur M. Patel PhD","doi":"10.1016/j.nano.2023.102662","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span><span>Oral cancer is a type of cancer that develops in the mouth and is one of the deadliest malignancies<span> in the world. Currently surgical, radiation therapy, and chemotherapy are most common </span></span>treatments<span>. Better treatment and early detection strategies are required. Chemotherapeutic drugs fail frequently due to toxicity and poor tumor targeting. There are high chances of failure of chemotherapeutic drugs due to toxicity. Active, passive, and immunity-targeting techniques are devised for tumor-specific activity. Nanotechnology-based drug delivery systems are the best available solution and important for precise targeting. </span></span>Nanoparticles<span><span>, liposomes<span><span>, exosomes, and </span>cyclodextrins are nano-based carriers for drug delivery. Nanotechnology is being used to develop new techniques such as </span></span>intratumoral injections, </span></span>microbubble<span> mediated ultrasonic therapy<span>, phototherapies<span>, and site-specific delivery. This systematic review delves into the details of such targeted and nano-based drug delivery systems in order to improve </span></span></span></span>patient health and survival rates in oral cancer.</p></div>","PeriodicalId":396,"journal":{"name":"Nanomedicine: Nanotechnology, Biology and Medicine","volume":"49 ","pages":"Article 102662"},"PeriodicalIF":4.7000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine: Nanotechnology, Biology and Medicine","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963423000138","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 10
Abstract
Oral cancer is a type of cancer that develops in the mouth and is one of the deadliest malignancies in the world. Currently surgical, radiation therapy, and chemotherapy are most common treatments. Better treatment and early detection strategies are required. Chemotherapeutic drugs fail frequently due to toxicity and poor tumor targeting. There are high chances of failure of chemotherapeutic drugs due to toxicity. Active, passive, and immunity-targeting techniques are devised for tumor-specific activity. Nanotechnology-based drug delivery systems are the best available solution and important for precise targeting. Nanoparticles, liposomes, exosomes, and cyclodextrins are nano-based carriers for drug delivery. Nanotechnology is being used to develop new techniques such as intratumoral injections, microbubble mediated ultrasonic therapy, phototherapies, and site-specific delivery. This systematic review delves into the details of such targeted and nano-based drug delivery systems in order to improve patient health and survival rates in oral cancer.
期刊介绍:
Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.